The good protection of G-rk1 administrated by intranasal inoculation on PR8-infected mice suggests that it could potentially be developed into an anti-influenza aerosol, a common and practical drug administration strategy for respiratory infectious diseases in the clinic [50]. This evidence concerns the gene GRK1 and influenza.